Shivan Sivakumar

Shivan Sivakumar

University of Oxford

H-index: 14

Europe-United Kingdom

About Shivan Sivakumar

Shivan Sivakumar, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Pancreatic cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease

Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin …

Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy

Pseudotime dynamics of T-cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T-cells

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

Healthcare systems must get fair value for their data

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study

Shivan Sivakumar Information

University

Position

___

Citations(all)

2779

Citations(since 2020)

2431

Cited By

1066

hIndex(all)

14

hIndex(since 2020)

14

i10Index(all)

17

i10Index(since 2020)

17

Email

University Profile Page

Google Scholar

Shivan Sivakumar Skills & Research Interests

Pancreatic cancer

Top articles of Shivan Sivakumar

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease

Experimental hematology & oncology

2023/12/1

Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study

International journal of molecular sciences

2023/11/28

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin …

BMC cancer

2023/9/23

Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy

Cells

2023/3/9

Pseudotime dynamics of T-cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T-cells

iScience

2023/3/7

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

2023/1

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Healthcare systems must get fair value for their data

bmj

2022/6/27

Scott Hemphill
Scott Hemphill

H-Index: 17

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study

Gut

2022/6/27

PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma

Cancers

2022/4/27

The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma

Hepatobiliary Surgery and Nutrition

2022/4

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Editorial on" Perihilar Cholangiocarcinoma-Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers"

2022/3/4

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Biomarkers of response to PD-1 pathway blockade

2022/6/1

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Gene of the month: T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT)

Journal of Clinical Pathology

2022/1/20

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

A New Combination Immunotherapy in Advanced Melanoma

2022/1/6

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis

Journal of Clinical Medicine

2022/1

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical prediction model …

medRxiv

2021/1/1

Cell-free DNA TAPS provides multimodal information for early cancer detection

Science advances

2021/9/1

The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma

Cancers

2021/1

Dong Liu
Dong Liu

H-Index: 10

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma

Liver Cancer

2021

Shivan Sivakumar
Shivan Sivakumar

H-Index: 8

Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer

Cancers

2021/1

See List of Professors in Shivan Sivakumar University(University of Oxford)